Europe Prostate Cancer Diagnosis and Therapy Market Research Report Forecast to 2027
Market Overview
The Europe prostate cancer diagnosis and therapy market was valued at USD 4,002.70 million in 2020 and is expected to register a CAGR of 5.05% during the assessment period. Prostate cancer is a type of cancer that affects only males in the prostate gland cells and is highly treatable in the early stages. There are various approaches to diagnose and treat prostate cancer available in the market.
The Europe prostate cancer diagnosis and therapy market is emerging due to the rising prevalence rate of prostate cancer. The increasing expenditure on oncology medicine research is anticipated to drive the growth of the market during the forecast period. Additionally, the launching of new products will provide growth opportunities for the market in the future. However, the side effects of Therapy and shortage of skilled and experienced oncologists might hamper the market's growth in the forecast period.
Market Segmentation
Based on stage, the Europe prostate cancer diagnosis and therapy market is segmented into stage I, stage II, stage III, and stage IV. The Europe prostate cancer diagnosis and therapy market is driven due to the increasing consumption of oncogene-activating components such as tobacco and unhealthy lifestyle. Stage II held the largest market in 2020
Based on type, the Europe prostate cancer diagnosis and therapy market is segmented into prostatic adenocarcinoma, small cell carcinoma, and others. The other segment includes squamous cell carcinoma, neuroendocrine tumors, soft tissue sarcoma, and transitional cancer. Prostatic adenocarcinoma holds the largest market size owing to a large patient pool. The other factor contributing to the increase in prostatic cases are aging, smoking, and obesity.
In terms of components, the Europe prostate cancer diagnosis and therapy market is segmented into diagnosis and therapy. The diagnosis segment is further sub-segmented into tissue biopsy, diagnostic imaging, and others. The therapy segment is sub-segmented into chemotherapy, hormonal therapy, and immunotherapy. The diagnostic imaging segment is expected to hold the largest market size by diagnosis method during the forecast period. The Europe prostate cancer diagnosis and therapy market based on end user has been segmented into hospitals & clinics, specialty centers, and others. The others segment includes ambulatory surgical centers and research institutions.
Regional Analysis
The growing aging population, rising prevalence rate of prostate cancer across Europe, and the increasing awareness among the individuals coupled with the various government initiatives to promote the Therapy of prostate cancer in the early stages are some of the prominent factors driving the growth of the Europe prostate cancer diagnosis and therapy market. For instance, as per GLOBOCAN, in 2020, Europe reported 518.11 new prostate cancer cases per 100,000 population. Similarly, according to the European Alliance for Personalized Medicine, the number of men being diagnosed with prostate cancer in Europe has increased over recent years.
Major Players
The market players include Astellas Pharma, Inc., Johnson & Johnson Services, Inc, Bayer AG, Roche Holding AG, Ipsen S.A., Tolmar Inc., Ferring B.V., and Esaote Spa.
Companies Mentioned
Astellas Pharma
Inc.
Johnson & Johnson Services
Inc
Bayer AG
Roche Holding AG
Ipsen S.A.
Tolmar Inc.
Ferring B.V.
and Esaote Spa
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 2.5 Assumptions & Limitations
- 3 Research Methodology
- 3.1 Data Mining
- 3.2 Secondary Research
- 3.3 Primary Research
- 3.4 Breakdown Of Primary Respondents
- 3.5 Forecasting Techniques
- 3.6 Research Methodology For Market Size Estimation
- 3.6.1 Bottom-up Approach
- 3.6.2 Top-down Approach
- 3.7 Data Triangulation
- 3.8 Validation
- 4 Market Dynamics
- 4.1 Overview
- 4.2 Drivers
- 4.2.1 Rising Prevalence Rate Of Prostate Cancer
- 4.2.2 Increasing Expenditure On Oncology Medicine And Research
- 4.3 Restraints
- 4.3.1 Side-effects Of Therapy
- 4.3.2 Shortage Of Skilled And Experienced Oncologist
- 4.4 Opportunity
- 4.4.1 Launch Of Innovative Therapy Products
- 5 Market Factor Analysis
- 5.1 Value Chain Analysis
- 5.1.1 R&D
- 5.1.2 Manufacturing
- 5.1.3 Distribution & Sales
- 5.1.4 Post-sales Monitoring
- 5.2 Porter's Five Forces Model
- 5.2.1 Threat Of New Entrants
- 5.2.2 Bargaining Power Of Suppliers
- 5.2.3 Threat Of Substitutes
- 5.2.4 Bargaining Power Of Buyers
- 5.2.5 Intensity Of Rivalry
- 5.3 Impact Of Covid-19 On The Europe Prostate Cancer Diagnosis And Therapy Market
- 5.3.1 Impact On Supply Chain
- 5.3.2 Impact On Patients Suffering From Prostate Cancer
- 5.3.3 Impact On Pricing
- 5.3.4 Impact On Clinical Trials
- 6 Europe Prostate Cancer Diagnosis And Therapy Market, By Stages
- 6.1 Overview
- 6.2 Stage I
- 6.3 Stage Ii
- 6.4 Stage Iii
- 6.5 Stage Iv
- 7 Europe Prostate Cancer Diagnosis And Therapy Market, By Type
- 7.1 Overview
- 7.2 Prostatic Adenocarcinoma
- 7.3 Small Cell Carcinoma
- 7.4 Others
- 8 Europe Prostate Cancer Diagnosis And Therapy Market, By Component
- 8.1 Overview
- 8.2 Therapy
- 8.2.1 Hormonal Therapy
- 8.2.2 Chemotherapy
- 8.2.3 Radiotherapy Drugs
- 8.2.4 Immunotherapy
- 8.2.5 Others
- 8.3 Diagnosis
- 8.3.1 Diagnostic Imaging
- 8.3.2 Tissue Biopsy
- 8.3.3 Others
- 9 Europe Prostate Cancer Diagnosis And Therapy Market, By End User
- 9.1 Overview
- 9.2 Specialty Centers
- 9.3 Hospitals & Clinics
- 9.4 Others
- 10 Europe Prostate Cancer Diagnosis And Therapy Market, By Region/Country
- 10.1 Overview
- 10.2 Western Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Uk
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Rest Of Western Europe
- 10.3 Eastern Europe
- 10.3.1 Hungary
- 10.3.2 Poland
- 10.3.3 Russia
- 10.3.4 Rest Of Eastern Europe
- 10.4 Rest Of Europe
- 11 Competitive Landscape
- 11.6 Key Developments & Growth Strategies
- 11.6.1 Product Launch/Product Approval
- 11.6.2 Expansion
- 11.7 Financial Matrix
- 11.7.1 Sales (Usd Million),
- 11.7.2 Research & Development Expenditure (Usd Million),
- 12 Company Profiles
- 12.1 Abbvie Inc.
- 12.1.1 Company Overview
- 12.1.2 Financial Overview
- 12.1.3 Products/Services Offered
- 12.1.4 Products/Services Offered
- 12.1.5 Swot Analysis
- 12.1.6 Key Strategies
- 12.2 Astrazeneca
- 12.2.1 Company Overview
- 12.2.2 Financial Overview
- 12.2.3 Products/Services Offered
- 12.2.4 Key Developments
- 12.2.5 Swot Analysis
- 12.2.6 Key Strategies
- 12.3 Bayer Ag
- 12.3.1 Company Overview
- 12.3.2 Financial Overview
- 12.3.3 Products/Services Offered
- 12.3.4 Key Developments
- 12.3.5 Swot Analysis
- 12.3.6 Key Strategies
- 12.4 Sanofi
- 12.4.1 Company Overview
- 12.4.2 Financial Overview
- 12.4.3 Products/Services Offered
- 12.4.4 Key Developments
- 12.4.5 Swot Analysis
- 12.4.6 Key Strategies
- 12.5 Ipsen S.A.
- 12.5.1 Company Overview
- 12.5.2 Financial Overview
- 12.5.3 Products/Services Offered
- 12.5.4 Key Developments
- 12.5.5 Swot Analysis
- 12.5.6 Key Strategies
- 12.6 Astellas Pharma Inc.
- 12.6.1 Company Overview
- 12.6.2 Financial Overview
- 12.6.3 Products/Services Offered
- 12.6.4 Key Developments
- 12.6.5 Swot Analysis
- 12.6.6 Key Strategies
- 12.7 Ferring Pharmaceuticals
- 12.7.1 Company Overview
- 12.7.2 Financial Overview
- 12.7.3 Products/Services Offered
- 12.7.4 Key Developments
- 12.7.5 Swot Analysis
- 12.7.6 Key Strategies
- 12.8 Tolmar Pharmaceuticals, Inc.
- 12.8.1 Company Overview
- 12.8.2 Financial Overview
- 12.8.3 Products/Services Offered
- 12.8.4 Key Developments
- 12.8.5 Swot Analysis
- 12.8.6 Key Strategies
- 12.9 Johnson & Johnson Services Inc.
- 12.9.1 Company Overview
- 12.9.2 Financial Overview
- 12.9.3 Products/Services Offered
- 12.9.4 Key Developments
- 12.9.5 Swot Analysis
- 12.9.6 Key Strategies
- 12.10 Esaote Spa
- 12.10.1 Company Overview
- 12.10.2 Financial Overview
- 12.10.3 Products/Services Offered
- 12.10.4 Key Developments
- 12.10.5 Key Strategies
- 12.11 F. Hoffmann-la Roche Ltd
- 12.11.1 Company Overview
- 12.11.2 Financial Overview
- 12.11.3 Products/Services Offered
- 12.11.4 Key Developments
- 12.11.5 Swot Analysis
- 12.11.6 Key Strategies
- 13 Appendix
- 13.1 References
- 13.2 Related Reports
- List Of Tables
- Table 1 List Of Assumptions & Limitations
- Table 2 Primary Interviews And Information Gathering Process
- Table 3 Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 4 Stages Of Prostate Cancer With Gleason Score And Prostate-specific Antigen Levels
- Table 5 Europe: Prostate Cancer Diagnosis And Therapy Market, For Stage I, By Region, 2018–2027 (Usd Million)
- Table 6 Europe: Prostate Cancer Diagnosis And Therapy Market, For Stage Ii, By Region, 2018–2027 (Usd Million)
- Table 7 Europe: Prostate Cancer Diagnosis And Therapy Market, For Stage Iii, By Region, 2018–2027 (Usd Million)
- Table 8 Europe: Prostate Cancer Diagnosis And Therapy Market, For Stage Iv, By Region, 2018–2027 (Usd Million)
- Table 9 Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 10 Europe: Prostate Cancer Diagnosis And Therapy Market, For Prostatic Adenocarcinoma, By Region, 2018–2027 (Usd Million)
- Table 11 Europe: Prostate Cancer Diagnosis And Therapy Market, For Small Cell Carcinoma, By Region, 2018–2027 (Usd Million)
- Table 12 Europe: Prostate Cancer Diagnosis And Therapy Market, For Others, By Region, 2018–2027 (Usd Million)
- Table 13 Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 14 Europe: Prostate Cancer Diagnosis And Therapy Market, For Therapy, By Region, 2018–2027 (Usd Million)
- Table 15 Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 16 Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 17 Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 18 Europe: Prostate Cancer Diagnosis And Therapy Market, For Diagnosis, By Region, 2018–2027 (Usd Million)
- Table 19 Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 20 Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 21 Europe: Prostate Cancer Diagnosis And Therapy Market, For Speciality Centers, By Region, 2018–2027 (Usd Million)
- Table 22 Europe: Prostate Cancer Diagnosis And Therapy Market, For Hospitals & Clinics, By Region, 2018–2027 (Usd Million)
- Table 23 Europe: Prostate Cancer Diagnosis And Therapy Market, For Others, By Region, 2018–2027 (Usd Million)
- Table 24 Europe: Prostate Cancer Diagnosis And Therapy Market, By Region, 2018–2027 (Usd Million)
- Table 25 Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 26 Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 27 Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 28 Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 29 Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 30 Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 31 Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 32 Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 33 Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Western Country, 2017–2027 (Usd Million)
- Table 34 Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 35 Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 36 Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 37 Western Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 38 Western Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 39 Western Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 40 Western Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 41 Western Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 42 Germany: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 43 Germany: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 44 Germany: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 45 Germany: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 46 Germany: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 47 Germany: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 48 Germany: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 49 Germany: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 50 France: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 51 France: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 52 France: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 53 France: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 54 France: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 55 France: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 56 France: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 57 France: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 58 Uk: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 59 Uk: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 60 Uk: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 61 Uk: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 62 Uk: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 63 Uk: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 64 Uk: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 65 Uk: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 66 Italy: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 67 Italy: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 68 Italy: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 69 Italy: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 70 Italy: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 71 Italy: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 72 Italy: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 73 Italy: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 74 Spain: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 75 Spain: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 76 Spain: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 77 Spain: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 78 Spain: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 79 Spain: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 80 Spain: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 81 Spain: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 82 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 83 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 84 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 85 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 86 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 87 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 88 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 89 Rest Of Western Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 90 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Eastern Country, 2017–2027 (Usd Million)
- Table 91 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 92 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 93 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 94 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 95 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 96 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 97 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 98 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 99 Hungary: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 100 Hungary: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 101 Hungary: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 102 Hungary: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 103 Hungary: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 104 Hungary: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 105 Hungary: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 106 Hungary: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 107 Poland: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 108 Poland: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 109 Poland: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 110 Poland: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 111 Poland: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 112 Poland: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 113 Poland: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 114 Poland: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 115 Russia: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 116 Russia: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 117 Russia: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 118 Russia: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 119 Russia: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 120 Russia: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 121 Russia: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 122 Russia: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 123 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 124 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 125 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 126 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 127 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 128 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 129 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 130 Rest Of Eastern Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 131 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market, By Stages, 2018–2027 (Usd Million)
- Table 132 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market, By Type, 2018–2027 (Usd Million)
- Table 133 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market, By Component, 2018–2027 (Usd Million)
- Table 134 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market For Therapy, By Type, 2018–2027 (Usd Million)
- Table 135 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market For Hormonal Therapy, By Type, 2018–2027 (Usd Million)
- Table 136 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market For Chemotherapy, By Type, 2018–2027 (Usd Million)
- Table 137 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market For Diagnosis, By Type, 2018–2027 (Usd Million)
- Table 138 Rest Of Europe: Prostate Cancer Diagnosis And Therapy Market, By End User, 2018–2027 (Usd Million)
- Table 139 Major Players In The Global Prostate Cancer Diagnosis And Therapy Market
- Table 140 Most Active Players In The Global Prostate Cancer Diagnosis And Therapy Market
- Table 141 Product Launch/Product Approval
- Table 142 Expansion
- Table 143 Abbvie Inc.: Products Offered
- Table 144 Abbvie Inc.: Products Offered
- Table 145 Astrazeneca: Products/Services Offered
- Table 146 Astrazeneca: Key Developments
- Table 147 Bayer Ag: Products/Services Offered
- Table 148 Bayer Ag: Key Developments
- Table 149 Sanofi: Products/Services Offered
- Table 150 Ipsen S.A.: Products/Services Offered
- Table 151 Ipsen S.A.: Key Developments
- Table 152 Astellas Pharma Inc.: Products/Services Offered
- Table 153 Astellas Pharma Inc.: Key Developments
- Table 154 Ferring Pharmaceuticals.: Products/Services Offered
- Table 155 Tolmar Pharmaceuticals, Inc: Products/Services Offered
- Table 156 Johnson & Johnson Services Inc. Products/Services Offered
- Table 157 Esaote Spa: Products/Services Offered
- Table 158 F. Hoffmann-la Roche Ltd: Products/Services Offered
- List Of Figures
- Figure 1 Market Synopsis
- Figure 2 Market Structure: Europe Prostate Cancer Diagnosis And Therapy Market
- Figure 3 Bottom-up And Top-down Approaches
- Figure 4 Market Dynamics: Europe Prostate Cancer Diagnosis And Therapy Market
- Figure 5 Driver Impact Analysis
- Figure 6 Restraint Impact Analysis
- Figure 7 Value Chain Analysis: Europe Prostate Cancer Diagnosis And Therapy Market
- Figure 8 Porter's Five Forces Analysis: Europe Prostate Cancer Diagnosis And Therapy Market
- Figure 9 Europe Prostate Cancer Diagnosis And Therapy Market, By Stages, 2020 & 2027 (Usd Million)
- Figure 10 Europe Prostate Cancer Diagnosis And Therapy Market, By Type, 2020 & 2027 (Usd Million)
- Figure 11 Europe Prostate Cancer Diagnosis And Therapy Market, By Component, 2020 & 2027 (Usd Million)
- Figure 12 Europe Prostate Cancer Diagnosis And Therapy Market, By End User, 2020 & 2027 (Usd Million)
- Figure 13 Europe: Prostate Cancer Diagnosis And Therapy Market Share, By Region 2020 (%)
- Figure 14 Western Europe: Prostate Cancer Diagnosis And Therapy Market Share, By Region 2020 (%)
- Figure 15 Eastern Europe: Prostate Cancer Diagnosis And Therapy Market Share, By Region 2020 (%)
- Figure 16 Benchmarking Of Major Competitors
- Figure 17 Major Strategy Adopted By Key Players In The Global Prostate Cancer Diagnosis And Therapy Market
- Figure 18 Global Prostate Cancer Diagnosis And Therapy Market: Competitive Landscape
- Figure 19 Sales (Usd Million),
- Figure 20 Research & Development Expenditure
- Figure 21 Abbvie Inc.: Financial Overview Snapshot
- Figure 22 Abbvie Inc.: Swot Analysis
- Figure 23 Astrazeneca: Financial Overview Snapshot
- Figure 24 Astrazeneca: Swot Analysis
- Figure 25 Bayer Ag: Financial Overview Snapshot
- Figure 26 Bayer Ag: Swot Analysis
- Figure 27 Sanofi: Financial Overview Snapshot
- Figure 28 Sanofi: Swot Analysis
- Figure 29 Ipsen S.A.: Financial Overview Snapshot
- Figure 30 Ipsen S.A.: Swot Analysis
- Figure 31 Astellas Pharma Inc.: Financial Overview Snapshot
- Figure 32 Astellas Pharma Inc.: Swot Analysis
- Figure 33 Ferring Pharmaceuticals.: Financial Overview Snapshot
- Figure 34 Ferring Pharmaceuticals: Swot Analysis
- Figure 35 Tolmar Pharmaceuticals, Inc.: Swot Analysis
- Figure 36 Johnson & Johnson Services Inc.: Financial Overview Snapshot
- Figure 37 Johnson & Johnson Services Inc.: Swot Analysis
- Figure 38 F. Hoffmann-la Roche Ltd: Financial Overview Snapshot
- Figure 39 F. Hoffmann-la Roche Ltd: Swot Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook